Skip to main content
Logo Logo Logo
  • Investors
    • For Investors
  • Job Seekers
    • Careers
  • Quick Links
    • Clinical Trials
    • Contact Us/Inquiries
  • Global English
    • AustriaDeutsch
    • BelgiumNederlands Français
    • BrazilPortuguês
    • CanadaFrançais English
    • Czech RepublicČeština
    • DenmarkDansk
    • FranceFrançais
    • GermanyDeutsch
    • IrelandEnglish
    • ItalyItaliano
    • Japan日本語
    • LuxembourgFrançais Deutsch
    • NetherlandsNederlands
    • PortugalPortuguês
    • SpainEspañol
    • SwedenSvenska
    • SwitzerlandFrançais Deutsch Italiano
    • Taiwan繁體中文
    • United KingdomEnglish
  • Our Company
    • About Alnylam
  • Our Science
    • The Science of RNAi
    • Pipeline
    • Clinical Trials
  • Our Products
    • Product Listing
  • Our News
    • General News
  • Global English
    • AustriaDeutsch
    • BelgiumNederlands Français
    • BrazilPortuguês
    • CanadaFrançais English
    • Czech RepublicČeština
    • DenmarkDansk
    • FranceFrançais
    • GermanyDeutsch
    • IrelandEnglish
    • ItalyItaliano
    • Japan日本語
    • LuxembourgFrançais Deutsch
    • NetherlandsNederlands
    • PortugalPortuguês
    • SpainEspañol
    • SwedenSvenska
    • SwitzerlandFrançais Deutsch Italiano
    • Taiwan繁體中文
    • United KingdomEnglish
  • Our Company
    • About Alnylam
  • Our Science
    • The Science of RNAi
    • Pipeline
    • Clinical Trials
  • Our Products
    • Product Listing
  • Our News
    • General News
  • Investors

    Investors
    • For Investors
  • Job Seekers

    Job Seekers
    • Careers
  • Quick Links

    Quick Links
    • Clinical Trials
    • Contact Us/Inquiries

Our Products

Our Products

Approved in Canada

AMVUTTRA® (vutrisiran)


Click here to view Product Monograph ›
Cliquez ici pour la monographie du produit ›

ONPATTRO® (patisiran)


Click here to view Product Monograph ›
Cliquez ici pour la monographie du produit ›

GIVLAARI® (givosiran)


Click here to view Product Monograph ›
Cliquez ici pour la monographie du produit ›

OXLUMO® (lumasiran)


Click here to view Product Monograph ›
Cliquez ici pour la monographie du produit ›
  • Our Company
  • Our Science
  • Our Products
  • Our News
  • Investors
  • Medical Professionals
  • Job Seekers
  • Clinical Trials
  • Transparency
  • Capella
  • Contact Us
  • Privacy Policy
  • Legal Notice

Copyright ©  Alnylam Pharmaceuticals, Inc. — All Rights Reserved

Corp-CAN-00021, March 2025

This website is intended for residents of Canada only.

 
 
 

YOU ARE NOW LEAVING ALNYLAM.CA

You are are now directed to another site.

CONTINUE ›

 

YOU ARE NOW BEING REDIRECTED

You are now leaving www.alnylam.ca and going to our global website (www.alnylam.com), which is in English.

Continue ›

 

YOU ARE NOW BEING REDIRECTED

You are now leaving www.alnylam.ca and going to our global website (www.alnylam.com), which is in English.

Continue ›